GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » PSYC Corp (OTCPK:PSYC) » Definitions » Intrinsic Value: Projected FCF

PSYC (PSYC) Intrinsic Value: Projected FCF : $0.00 (As of Jun. 03, 2024)


View and export this data going back to 2007. Start your Free Trial

What is PSYC Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-03), PSYC's Intrinsic Value: Projected FCF is $0.00. The stock price of PSYC is $0.0013. Therefore, PSYC's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for PSYC's Intrinsic Value: Projected FCF or its related term are showing as below:

PSYC's Price-to-Projected-FCF is not ranked *
in the Media - Diversified industry.
Industry Median: 0.88
* Ranked among companies with meaningful Price-to-Projected-FCF only.

PSYC Intrinsic Value: Projected FCF Historical Data

The historical data trend for PSYC's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PSYC Intrinsic Value: Projected FCF Chart

PSYC Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec16
Intrinsic Value: Projected FCF
- - - - -

PSYC Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Dec14 Mar15 Jun15 Sep15 Mar16 Jun16 Sep16 Dec16 Jun17 Sep22 Sep23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PSYC's Intrinsic Value: Projected FCF

For the Advertising Agencies subindustry, PSYC's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PSYC's Price-to-Projected-FCF Distribution in the Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, PSYC's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where PSYC's Price-to-Projected-FCF falls into.



PSYC Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



PSYC  (OTCPK:PSYC) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

PSYC's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.0013/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PSYC Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of PSYC's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PSYC (PSYC) Business Description

Traded in Other Exchanges
N/A
Address
2881 South Valley View Boulevard, Suite 9, Las Vegas, NV, USA, 89102
PSYC Corp is a media-focused company serving the expanding industry and community of medicinal psychedelics. Through its media platform, Psychedelic Spotlight, the company has positioned itself right at the very core of the psychedelics renaissance. Technical420 is also one such platform that provides information and analysis on public and private companies. These platforms provide the Company with an opportunity to dominate the intersection of cannabis and psychedelics as a media leader. Along with its subsidiary, the group offers public relations and media-focused services to companies within the medicinal psychedelics industry and other niche industries that includes cannabis, health, and wellness, and sports, among others.